Hedeker Wealth’s Eli Lilly LLY Stock Holding History

Hedeker Wealth’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$10.8M	Sell	9,035 -17	-0.2%	-$17.4K	2.07%	17
2026 Q1	$8.33M	Hold	9,052	–	–	1.76%	20
2025 Q4	$9.73M	Buy	9,052 +7,150	+376%	+$6.84M	2.04%	14
2025 Q3	$1.45M	Hold	1,902	–	–	0.3%	66
2025 Q2	$1.48M	Sell	1,902 -35	-2%	-$27.2K	0.35%	62
2025 Q1	$1.6M	Buy	1,937 +7	+0.4%	+$5.83K	0.43%	61
2024 Q4	$1.49M	Buy	1,930 +173	+10%	+$143K	0.37%	62
2024 Q3	$1.56M	Hold	1,757	–	–	0.41%	59
2024 Q2	$1.59M	Sell	1,757 -40	-2%	-$32K	0.46%	54
2024 Q1	$1.4M	Hold	1,797	–	–	0.4%	65
2023 Q4	$1.05M	Hold	1,797	–	–	0.33%	74
2023 Q3	$965K	Hold	1,797	–	–	0.34%	73
2023 Q2	$843K	Sell	1,797 -324	-15%	-$136K	0.28%	82
2023 Q1	$728K	Sell	2,121 -3	-0.1%	-$1.01K	0.26%	79
2022 Q4	$777K	Hold	2,124	–	–	0.29%	80
2022 Q3	$686K	Hold	2,124	–	–	0.27%	80
2022 Q2	$704K	Hold	2,124	–	–	0.24%	78
2022 Q1	$608K	Sell	2,124 -2	-0.1%	-$515	0.18%	77
2021 Q4	$587K	Buy	2,126 +8	+0.4%	+$2.03K	0.17%	79
2021 Q3	$489K	Sell	2,118 -382	-15%	-$94.3K	0.15%	78
2021 Q2	$573K	Hold	2,500	–	–	0.18%	69
2021 Q1	$467K	Hold	2,500	–	–	0.16%	61
2020 Q4	$422K	Hold	2,500	–	–	0.15%	62
2020 Q3	$370K	Hold	2,500	–	–	0.18%	64
2020 Q2	$410K	Hold	2,500	–	–	0.21%	61
2020 Q1	$346K	Hold	2,500	–	–	0.22%	56
2019 Q4	$328K	Hold	2,500	–	–	0.18%	58
2019 Q3	$279K	Hold	2,500	–	–	0.17%	58
2019 Q2	$276K	Hold	2,500	–	–	0.17%	56
2019 Q1	$289K	Hold	2,500	–	–	0.22%	63
2018 Q4	$289K	Hold	2,500	–	–	0.23%	63
2018 Q3	$268K	Hold	2,500	–	–	0.19%	65
2018 Q2	$213K	Buy	+2,500	New	+$205K	0.16%	70
2018 Q1	–	Sell	-2,500	Closed	-$211K	–	71
2017 Q4	$211K	Sell	2,500 -500	-17%	-$42.5K	0.16%	69
2017 Q3	$256K	Hold	3,000	–	–	0.23%	67
2017 Q2	$246K	Hold	3,000	–	–	0.24%	81
2017 Q1	$252K	Hold	3,000	–	–	0.24%	87
2016 Q4	$220K	Buy	3,000 +2,760	+1,150%	+$206K	0.18%	114
2016 Q3	$3K	Sell	240 -5,010	-95%	-$401K	0.16%	67
2016 Q2	$413K	Hold	5,250	–	–	0.36%	95
2016 Q1	$378K	Hold	5,250	–	–	0.35%	61
2015 Q4	$442K	Hold	5,250	–	–	0.39%	58
2015 Q3	$439K	Sell	5,250 -2,376	-31%	-$201K	0.38%	64
2015 Q2	$636K	Sell	7,626 -600	-7%	-$45.7K	0.51%	51
2015 Q1	$596K	Sell	8,226 -3,150	-28%	-$224K	0.49%	53
2014 Q4	$785K	Buy	+11,376	New	+$768K	0.63%	44

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Hedeker Wealth's LLY Position: Q2 2026 in Review

Hedeker Wealth reduced its Eli Lilly (LLY) stake by 0.19% in Q2 2026, selling an estimated $17.4K and leaving 9,035 shares worth $10.8M. The position accounts for 2.07% of the portfolio, ranked #17.

Hedeker Wealth first reported a position in LLY in Q4 2014 and has held it in 46 quarters since. 4,602 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Hedeker Wealth held 9,035 shares of Eli Lilly worth $10.8M as of Q2 2026.
Hedeker Wealth sold 17 Eli Lilly shares in Q2 2026, an estimated $17.4K.
Eli Lilly made up 2.07% of Hedeker Wealth's portfolio in Q2 2026, its #17 holding.
Hedeker Wealth first reported a position in Eli Lilly in Q4 2014 and has held it in 46 quarters since.
4,602 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Hedeker Wealth's 13F filing for Q2 2026, filed 4 Aug 2026.